A major activity of ZIKA-VID was a comprehensive comparative analysis of the accuracy of second generation ZIKV diagnostic assays for use in LAC populations in pregnancy and childhood, which informed a theoretical model to address uncertainty in diagnosis that could prove useful not only in ZIKV but also in future emerging infections.
Results
This paper highlights the low sensitivity of ZIKV IgM testing in DENV endemic populations, the poor specificity of first generation ZIKV IgG and IgM assays and the value of the plaque neutralization test (PRNT), the most accurate reference assay for underpinning testing strategies in these studies.
Among the 3 novel IgG assays evaluated, BNITM / Hamburg Blackbox EIA IgG assay showed best sensitivity and specificity is also in use and was therefore introduced into three consortium sites (Rio, Haiti, and Jamaica) because of its good performance, excellent accuracy, and availability.
Additional work on optimization of diagnostic PCR assay was performed which has the potential to enhance future surveillance of ZIKV infections, particularly in communities underserved by laboratory services where cases in these communities often present late to clinical services.